论文部分内容阅读
目的分析卡托普利与美托洛尔联合方案治疗慢性心力衰竭的临床效果。方法选取2011年6月份至2012年4月份患慢性心力衰竭的患者143例为研究对象,随机分为两组,一组为实验组(卡托普利联合美托洛尔方案组)71例,一组为对照组(卡托普利组)72例。观察两组患者治疗后的效果。结果实验组治疗效果以及治疗后的平均心率、平均收缩压、平均舒张压,治疗前后的改善情况明显好于对照组。以上差异均显著,P<0.05。结论卡托普利与美托洛尔联合用于治疗慢性心率衰竭的临床效果明确,患者的心功能能够得到明显的改善,患者的生命质量得到提高。
Objective To analyze the clinical effect of captopril combined with metoprolol in the treatment of chronic heart failure. Methods A total of 143 patients with chronic heart failure from June 2011 to April 2012 were selected and divided into two groups randomly. One group consisted of 71 patients in the experimental group (captopril combined with metoprolol group) One group was control group (Captopril group) 72 cases. Observe the effect of two groups of patients after treatment. Results The experimental group and the average heart rate after treatment, mean systolic blood pressure, mean diastolic blood pressure, before and after treatment were significantly better than the control group. The above differences were significant, P <0.05. Conclusion The combination of captopril and metoprolol in the treatment of chronic heart failure has a clear clinical effect. The patient’s cardiac function can be significantly improved, and the quality of life of patients is improved.